Atlanta, Georgia – August 11, 2026 – (KOREWIRE) – Impiricus announced today that it has been ranked No. 14 on the 2026 Inc. 5000 list, the annual list of the fastest-growing private companies in America. The list is the most recognized ranking of the nation’s most successful independent and entrepreneurial businesses, recognizing companies that have achieved remarkable growth while driving innovation, creating jobs, and shaping the future of the economy. Past honorees include companies such as Microsoft, Meta, Chobani, Oracle, and Patagonia.
“Our 11,691% growth rate is a powerful validation of the problem we set out to solve: physicians need less noise and better access to the support that helps them care for patients,” said Dr. Osama Hashmi, dermatologist, CEO and co-founder of Impiricus. “Earning the No. 14 spot on the Inc. 5000 reflects the trust we’ve built with physicians and life sciences leaders, and the extraordinary work of our team. Now we’re taking that foundation even further, building agentic AI that turns physician engagement into real-time action and helps patients access treatment faster.”
Impiricus is building the agentic AI infrastructure for the next generation of healthcare commercialization, transforming physician engagement from information delivery to real-time clinical action. Its technology helps life sciences companies detect physician needs and connect HCPs with relevant clinical resources, patient support, and field teams at the exact time those resources can make a difference. Impiricus programs deliver measurable impact across major therapeutic areas, reaching white-space, digitally dark, and historically underserved physicians, helping accelerate patient access to treatment across the US.
“Every company on the Inc. 5000 has a story of perseverance, smart decision making, and a refusal to sit still,” says Mike Hofman, editor-in-chief of Inc. “Their growth reflects more than strong financial performance–it reflects creativity, resilience, and the customer focus required to build companies that make a lasting impact. We congratulate all honorees on this significant achievement.”
This year’s Inc. 5000 recognizes a new class of companies redefining what growth looks like. From AI and advanced manufacturing to healthcare, consumer products, and professional services, these businesses are expanding their impact and proving that entrepreneurial ambition continues to fuel the U.S. economy. Among the 5,000 companies on the list, the median three-year revenue growth rate was 130%, and those companies have collectively added more than 627,208 jobs to the U.S. economy over the past three years.
For the full Inc. 5000 list, honoree company profiles, and a searchable database by industry and location, please visit: www.inc.com/inc5000.
Inc. 5000 List Methodology
Companies on the 2026 Inc. 5000 are ranked according to percentage revenue growth from 2022 to 2025. To qualify, companies must have been founded and generating revenue by March 31, 2022. They must be U.S.-based, privately held, for-profit, and independent—not subsidiaries or divisions of other companies—as of December 31, 2025. (Since then, some on the list may have gone public or been acquired.) The minimum revenue required for 2022 is $100,000; the minimum for 2025 is $2 million. As always, Inc. reserves the right to decline applicants for subjective reasons.
About Impiricus
Impiricus is the first Agentic Commercialization Platform for healthcare. Founded by a practicing physician and a senior pharmaceutical executive, Impiricus is transforming how life sciences companies support physicians while accelerating patient access to life-saving treatments. Powered by the largest opted-in network of healthcare providers, its agentic AI platform delivers the right clinical resources, support, and connections exactly when and where physicians need them. Recognized by Deloitte as the #1 fastest-growing company in North America on the 2025 Technology Fast 500™, Impiricus provides the agentic AI infrastructure that transforms healthcare commercialization from information delivery to real-time clinical action. For more information, visit www.impiricus.com.
About Inc.
Inc. is the leading media brand and playbook for the entrepreneurs and business leaders shaping our future. Through its journalism, Inc. aims to inform, educate, and elevate the profile of its community: the risk-takers, the innovators, and the ultra-driven go-getters who are creating the future of business. Inc. is published by Mansueto Ventures LLC, along with fellow leading business publication Fast Company. For more information, visit www.inc.com.
Media Contact:
Yilan Yang, Executive Vice President, Marketing and Growth
Impiricus
yilan.yang@impiricus.com
617-485-6582